P664-0373 Screening compound: N~2~-{2-[4-(3-ethyl-5-methyl[1,2,4]triazolo[4,3-a]pyrimidin-7-yl)piperazino]-1-methyl-2-oxoethyl}-2-furamide

P664-0373 Screening compound: N~2~-{2-[4-(3-ethyl-5-methyl[1,2,4]triazolo[4,3-a]pyrimidin-7-yl)piperazino]-1-methyl-2-oxoethyl}-2-furamide
P664-0373 Screening compound: N~2~-{2-[4-(3-ethyl-5-methyl[1,2,4]triazolo[4,3-a]pyrimidin-7-yl)piperazino]-1-methyl-2-oxoethyl}-2-furamide alternative view

Chemical Structure Depiction of ChemDiv screening compound P664-0373
N~2~-{2-[4-(3-ethyl-5-methyl[1,2,4]triazolo[4,3-a]pyrimidin-7-yl)piperazino]-1-methyl-2-oxoethyl}-2-furamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P664-0373

Molecular Formula

C20H25N7O3 (C20 H25 N7 O3)

Compound Name

N~2~-{2-[4-(3-ethyl-5-methyl[1,2,4]triazolo[4,3-a]pyrimidin-7-yl)piperazino]-1-methyl-2-oxoethyl}-2-furamide

IUPAC name

N-[1-(4-{3-ethyl-5-methyl-[124]triazolo[43-a]pyrimidin-7-yl}piperazin-1-yl)-1-oxopropan-2-yl]furan-2-carboxamide

SMILES

CCc(n1c(C)c2)nnc1nc2N(CC1)CCN1C(C(C)NC(c1ccco1)=O)=O

InChI

InChI=1S/C20H25N7O3/c1-4-16-23-24-20-22-17(12-13(2)27(16)20)25-7-9-26(10-8-25)19(29)14(3)21-18(28)15-6-5-11-30-15/h5-6,11-12,14H,4,7-10H2,1-3H3,(H,21,28)

InChI Key

HMYIOQMLRJBFPG-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27610049

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

411.46

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

0.963

Distribution Coefficient, logD

0.962

Water Solubility, LogSw

-1.92

Polar Surface Area

84.311

Acid Dissociation Constant (pKa)

12.21

Base Dissociation Constant (pKb)

3.84

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

45.00

P664-0373 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • GPCR
  • Proteases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with P664-0373 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P664-0373?
Check Price and Availability of P664-0373, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P664-0373 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P664-0373
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P664-0373
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P664-0373 available by request